The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for ...

Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...

Researchers have found in two longitudinal cohorts that Incorporating chest CT imaging and respiratory symptoms into the ...

At the recent AWS Summit in Washington, D.C., hosted by Amazon Web Services, a panel of healthcare IT experts discussed the ...

A recent population-based study published in the Journal of American Medical Association identified a modest increase in ...

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

“This research shows that people with COPD seem to gather a lot more carbon in their lung cells. These cells also look and ...

There are various problems in administering asthma and COPD treatment to patients. In asthma, for example, people don't necessarily perceive that they have to take their treatment every day.

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.